Founder and Managing Partner, Frazier Healthcare Ventures
CEO and Fund Manager, Renaissance Venture Capital Fund
Vice President for Corporate Engagement, Rose-Hulman Institute of Technology
Founder, The Haul Company
This is one of the few conferences for medicinal chemists working in pharma and biotech, and is focused on discovery and optimization challenges of small molecule drug candidates. New this year are Constrained Peptides and Macrocyclics and GPCR-Based Drug Design which represent areas of chemistry where evolving technologies are leading to renewed interest. They nicely complement the most popular meetings from the past few years: Anti-Inflammatories, Fragment-Based Drug Discovery, Kinase Inhibitor Chemistry and Protein-Protein Interactions. More information and online registration is here.